Imperial Receives Global Excellence Award

« Back to News

Imperial Awarded the Most Innovative Clinical Trial Solutions Provider - Midwest USA

GRAND RAPIDS, Michigan, September 27, 2023—Imperial Clinical Research Services has been honored with a Global Excellence Award by Global Health & Pharma. The organization named Imperial the Most Innovative Clinical Trial Solutions Provider - Midwest USA.

Global Health & Pharma’s awards recognize excellence for services within the health care and pharmaceutical industries. The awards highlight those at the cutting edge of industry advances working tirelessly to ensure that patients receive the very best medicine, processes, care, and health services.

“All of us at Imperial are honored by this recognition,” said Dan McDonald, Imperial vice president of business development. “We are happy to see Global Health & Pharma acknowledge Imperial’s important work in research, as well as the core values and culture that differentiates us. Our clients know they will receive a level of attention and care that larger firms fail to deliver.“

Global Health & Pharma undertakes an extensive research process, and it assesses award candidates based on objective factors including company performance, product development, customer reviews, and industry recognition.
Imperial is featured in Global Health & Pharma’s magazine in an article titled “Imperial Supports the Clinical Trials Industry With a Focus on Patients.” The article describes the services Imperial provides to sponsors and contract research organizations, a description of its company culture, and the trials industry future Imperial envisions. The article can be viewed here:

Imperial Clinical Research Services, based in Grand Rapids, Michigan, provides first-in-class support for the clinical trial industry through creating branding and research protocol-based content and design for study and site materials, print and digital production, ancillary trial supplies and equipment management, translation services, and patient engagement.